Update on stem cell biotechs: an ethical investment, but risky and requiring patience.
When I was at the recent World Stem Cell Summit, I had the opportunity to meet a ton of people from all different walks of life including other scientists in academia, folks in the biotech/pharma industry, and many inspiring patient advocates. A number of people were curious about my view on how the stem cell-related …
Update on stem cell biotechs: an ethical investment, but risky and requiring patience. Read More »